Randomized trial data support the use of either TNF or IL-17 inhibitors to treat axial spondyloarthritis, based on patient ...

Tumor necrosis factor inhibitors were not linked to additional weight gain in patients with psoriatic arthritis when age-related changes were considered.

Early initiation of TNF inhibitors among children with non-sJIA led to significant and sustained improvements in disease activity.

The updated indication allows the use of Rinvoq prior to the use of tumor necrosis factor blocking agents in certain patients ...

WASHINGTON (Reuters) - U.S. health regulators have received more reports of rare blood cancer in young patients taking a class of anti-inflammatory drugs used to treat digestive disorders. The drugs, ...

The Phase 1 clinical trial is a randomized, double-blind, placebo-controlled study evaluating single and multiple ascending doses of FT2109 in healthy adult volunteers. The trial will assess the ...

JERSEY CITY, N.J. & INCHEON, Korea--(BUSINESS WIRE)--Organon & Co. (NYSE: OGN) & Samsung Bioepis Co., Ltd. today announced that HADLIMA™ (adalimumab-bwwd), a biosimilar referencing Humira (adalimumab) ...

ORLANDO -- Major cardiovascular event risk in patients with inflammatory bowel disease (IBD) was no greater with Janus kinase (JAK) inhibitors than with tumor necrosis factor (TNF) inhibitors, ...

Infants exposed to TNF inhibitors in utero or through breast milk show no increased risk for severe infections or impaired ...

CHICAGO -- Hitting rheumatoid arthritis (RA) early and hard, with targeted therapies as first-line treatment, appears to reduce the likelihood that it will reach the dreaded "difficult-to-treat" stage ...